Temporal arteritis. Aggressive treatment prevents visual complications.
Visual loss is the most common complication of temporal arteritis when the disease is misdiagnosed or undertreated, yet treatment recommendations vary among different medical disciplines. In this article, Dr Wind presents a case report and information from the medical literature illustrating different treatment regimens and visual outcomes in patients with temporal arteritis.
Wind
B E
BE
Department of Ophthalmology, Grandview Hospital and Medical Center, Dayton, OH 45405.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002985:Clinical Protocols; D013700:Giant Cell Arteritis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D014786:Vision Disorders / Q000209:etiology
D000305:Adrenal Cortex Hormones; D011241:Prednisone; D008775:Methylprednisolone